Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1245 studies found for:    ESR1
Show Display Options
Rank Status Study
1 Recruiting Study of ESR1 Mutations in Metastatic Breast Cancer
Condition: Metastatic Breast Cancer
Intervention: Biological: Determination of ESR1 mutations
2 Recruiting PAlbociclib and Circulating Tumor DNA for ESR1 Mutation Detection
Condition: Metastatic Breast Cancer
Interventions: Drug: Palbociclib 125mg;   Drug: Aromatase Inhibitors;   Drug: Fulvestrant Injectable Product
3 Completed An Open Label Study of Postmenopausal Women With Oestrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Treated With Everolimus (RAD001) With Exemestane, With Exploratory Epigenetic Marker Analysis
Condition: Oestrogen Receptor Positive Advanced Breast Cancer
Interventions: Drug: RAD001;   Drug: Exemestane
4 Completed Estrogen Receptors and Chronic Venous Disease
Conditions: Estrogen Excess;   Varicose Veins
Intervention: Procedure: Venous Surgery
5 Completed
Has Results
Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
Conditions: Estrogen Receptor Positive Tumor;   Breast Cancer
Interventions: Drug: eribulin mesylate;   Drug: capecitabine
6 Unknown  Validation of [18F]FES for Imaging of Brain Estrogen Receptors
Conditions: Psychiatric/Mood Disorder | Patient;   Estrogen Receptor Levels;   Premenopausal;   Postmenopausal
Intervention: Procedure: FES-PET
7 Completed
Has Results
A Study of the Effect of Estrogen on Estrogen Receptor Biomarkers in Healthy Postmenopausal Women (0000-094)(COMPLETED)
Condition: Postmenopause
Interventions: Drug: Comparator: placebo;   Drug: Comparator: Estrace
8 Recruiting Phase II Treatment of Metastatic Breast Cancer With Fulvestrant or Tamoxifen
Condition: Metastatic Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Tamoxifen
9 Recruiting GS-5829 in Combination With Exemestane or Fulvestrant Comparing With Exemestane or Fulvestrant Alone in Women With Advanced Estrogen Receptor Positive HER2- Breast Cancer
Condition: Advanced Estrogen Receptor Positive HER2- Breast Cancer
Interventions: Drug: GS-5829;   Drug: Exemestane;   Drug: Fulvestrant
10 Active, not recruiting Ruxolitinib in Estrogen Receptor Positive Breast Cancer
Condition: Estrogen-receptor Positive Invasive Metastatic Breast Cancer
Interventions: Drug: Ruxolitinib;   Drug: Exemestane
11 Completed BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: BKM120;   Drug: Fulvestrant;   Procedure: biopsy
12 Recruiting Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status
Condition: Breast Cancer
Interventions: Drug: Fluorestradiol (FES);   Procedure: PET/CT Imaging
13 Completed Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast Cancer
Condition: Hormon Receptor Positive Breast Cancer
14 Recruiting Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Drug: Raloxifene Hydrochloride;   Drug: Placebo
15 Recruiting Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer
Condition: Female Breast Cancer
Intervention: Drug: Toremifene; Anastrozole
16 Completed Estrogen Receptor Gene Mutations
Conditions: Mutations;   Hormones
17 Recruiting Pembrolizumab, Letrozole, and Palbociclib in Treating Patients With Stage IV Estrogen Receptor Positive Breast Cancer With Stable Disease That Has Not Responded to Letrozole and Palbociclib
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Postmenopausal;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Drug: Palbociclib;   Biological: Pembrolizumab
18 Recruiting The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307) for Negative Symptoms and Cognitive Impairment Associated With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: LY500307 150mg;   Drug: LY500307 75mg;   Drug: Placebo
19 Completed Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder;   Schizophreniform Disorder
Interventions: Drug: Raloxifene hydrochloride;   Other: Lactose Capsules
20 Recruiting Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Drug: Raloxifene hydrochloride;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.